Medpace Holdings ($MEDP) Insider Trading & Smart Money Activity
Medpace Holdings, Inc. ($MEDP) has 9 insider trades, 1 congress trade, 6 13F position changes and 2 analyst ratings on file. In the last 12 months on the open market, no insider bought and 1 insider sold ($110.49M), net -$110.49M.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 1
- Net insider $ (12 mo)
- -$110.49M
- Congress trades (12 mo)
- 1
- 13F moves on file
- 6
- Analyst ratings on file
- 2
MEDP insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 0 | 1 / 0 | 2 / 2 |
| Q3 2026 | 0 | 9 · $110.49M | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 1 / 1 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All MEDP insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 13F | PineStone Asset Management | Reduced | -280 sh | $923.79K | — | ||||||
| 13F | Burney Co/ | New | +4.76K sh | $2.97M | Read | ||||||
| Analyst | Mizuho | Reiterates to Outperform | PT $700 | +2.0% | — | ||||||
| Analyst | UBS | Raises to Neutral | PT $673 | -3.2% | — | ||||||
| Insider | Troendle August J.President & CEO | Sell (Open-market sale) | 21.97K sh | $13.74M | -3.2% | — | |||||
| Insider | Troendle August J.President & CEO | Sell (Open-market sale) | 26.70K sh | $16.58M | -3.1% | — | |||||
| Insider | Troendle August J.President & CEO | Sell (Open-market sale) | 2.41K sh | $1.49M | +0.7% | — | |||||
| Insider | Troendle August J.President & CEO | Sell (Open-market sale) | 154 sh | $95.57K | -3.1% | — | |||||
| Insider | Troendle August J.President & CEO | Sell (Open-market sale) | 27.83K sh | $17.29M | -3.6% | — | |||||
| Insider | Troendle August J.President & CEO | Sell (Open-market sale) | 16.08K sh | $10.11M | +1.1% | — | |||||
| Insider | Troendle August J.President & CEO | Sell (Open-market sale) | 49.02K sh | $30.79M | -1.3% | — | |||||
| Insider | Troendle August J.President & CEO | Sell (Open-market sale) | 21.88K sh | $13.64M | -1.3% | — | |||||
| Insider | Troendle August J.President & CEO | Sell (Open-market sale) | 10.88K sh | $6.75M | +0.9% | — | |||||
| Congress | David Taylor | Purchase | $1,001 - $15,000 | +4.2% | +12.6% | Read | |||||
| 13F | Fundsmith | Reduced | -19.90K sh | $33.19M | +4.2% | +12.6% | Read | ||||
| 13F | Mawer Investment Management | Added | +38.80K sh | $236.25M | -0.7% | +6.4% | — | ||||
| 13F | Pinestone Asset Management | Reduced | -22.06K sh | $1.40M | +1.5% | +8.1% | — | ||||
| 13F | Wasatch Advisors | Added | +125.62K sh | $409.87M | -20.4% | -16.5% | — |
1W / 1M / 6M = how MEDP moved from the trade or filing date.
Insider trading in MEDP: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Troendle August J. | President & CEO | 9 | -$110.49M | Sep 30, 2026 |
Members of Congress trading MEDP
Institutions moving MEDP (13F)
Analyst ratings on MEDP
| Date | Firm | Action | Rating | Price target | 1W | 1M | 6M | Story |
|---|---|---|---|---|---|---|---|---|
| Mizuho | Reiterates | Outperform | $665 → $700 | +2.0% | — | |||
| UBS | Raises | Neutral | $405 → $673 | -3.2% | — |
Frequently asked questions
Are MEDP insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 1 insider made 9 open-market sales worth $110.49M, a net -$110.49M.
What is the latest insider trade in MEDP?
Troendle August J., President & CEO filed a sell (open-market sale) of 21.97K sh worth $13.74M on Sep 30, 2026.
Which members of Congress traded MEDP?
1 disclosed trade by David Taylor. The latest was on May 15, 2026.
Which institutions changed their MEDP positions?
Recent 13F filers moving the stock include Pinestone Asset Management, Burney Co/, Fundsmith, Mawer Investment Management and Wasatch Advisors.
Other diagnostics & research stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.